Treatment Satisfaction of Patients with Lower Urinary Tract Symptoms: Randomised Controlled Trials vs. Real Life Practice

2000 ◽  
Vol 38 (Suppl. 1) ◽  
pp. 40-47 ◽  
Author(s):  
Martin C. Michel ◽  
Mark Goepel
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Treatment Satisfaction ◽  
Randomised Controlled Trials ◽  
Lower Urinary Tract ◽  
Real Life ◽  
Controlled Trials ◽  
Urinary Tract Symptoms ◽  
Randomised Controlled ◽  
Lower Urinary

scholarly journals Self management for men with lower urinary tract symptoms: randomised controlled trial

BMJ ◽  
2006 ◽  
Vol 334 (7583) ◽  
pp. 25 ◽  
Author(s):  
Christian T Brown ◽  
Tet Yap ◽  
David A Cromwell ◽  
Lorna Rixon ◽  
Liz Steed ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Randomised Controlled Trial ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Controlled Trial ◽  
Self Management ◽  
Urinary Tract Symptoms ◽  
Randomised Controlled ◽  
Lower Urinary

scholarly journals The Add-On Effect of Solifenacin for Patients with Remaining Overactive Bladder after Treatment with Tamsulosin for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction

2010 ◽  
Vol 2010 ◽  
pp. 1-5 ◽  
Author(s):  
Naoya Masumori ◽  
Taiji Tsukamoto ◽  
Masahiro Yanase ◽  
Hiroki Horita ◽  
Masaharu Aoki
Keyword(s):  
Urinary Tract ◽  
Overactive Bladder ◽  
Symptom Score ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Urine Volume ◽  
Real Life ◽  
Benign Prostatic Obstruction ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Objectives. To investigate the add-on effect of solifenacin for Japanese men with remaining overactive bladder (OAB) symptoms after tamsulosin monotherapy for lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) in real-life clinical practice.Methods. Patients aged ≥ 50 having remaining OAB symptoms (≥ 3 of OAB symptom score (OABSS) with ≥2 of urgency score) after at least 4 weeks treatment by 0.2 mg of tamsulosin for BPO/LUTS received 2.5 or 5.0 mg of solifenacin for 12 weeks. The International Prostate Symptom Score (IPSS), QOL index and OABSS, maximum flow rate (Qmax) and postvoid residual urine volume (PVR) were determined.Results. A total of 48 patients (mean age 72.5 years) completed the study. There were significant improvement in IPSS (15.1 to 11.2) and QOL index (4.2 to 3.0) by add-on of solifenacin. Although the IPSS storage symptom score was significantly improved, there were no changes observed in the IPSS voiding symptom score. The OABSS showed significant improvement (8.0 to 4.8). No changes were observed in Qmax and PVR.Conclusions. Under the supervision of an experienced urologist, the additional administration of solifenacin to patients with BPO/LUTS treated with tamsulosin, is effective in controlling remaining OAB symptoms.

Sign in / Sign up

Export Citation Format

Share Document